Home » Topics » BioWorld Science

BioWorld Science
RSS

"Typical" screening method yields novel antifungal drug class

Oct. 18, 2018

DWORF binding dwarfs PLN, helps failing hearts

Oct. 18, 2018

Tumors, T cells, TFs

Oct. 18, 2018

Allergan plans ubrogepant NDA filing following successful outcome of safety studies

Oct. 17, 2018

FDA approves Talzenna for germline BRCA-mutated HER2-negative breast cancer

Oct. 17, 2018

OCLI-070 inhibits osteoclast differentiation in ligature-induced experimental osteolysis

Oct. 17, 2018

Phase III SUNRISE 2 trial of lemborexant in insomnia meets key endpoints

Oct. 17, 2018

Zhejiang Hisun Pharmaceutical Co. patents acetyl-CoA carboxylase inhibitors

Oct. 17, 2018

Phase II study of avexitide in post-bariatric hypoglycemia meets key endpoints

Oct. 17, 2018

STING modulators identified at Boehringer Ingelheim

Oct. 17, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026